Skip to main content
. 2023 Jun 15;9(6):e16930. doi: 10.1016/j.heliyon.2023.e16930

Fig. 3.

Fig. 3

High serum lipid content i.e. HDL, LDL, total cholesterol and Triglycerides caused by scopolamine was reduced by folicitin as seen in scopolamine and scopolamine plus folicitin-treated groups while their levels were statistically compared among control, scopolamine and scopolamine plus folicitin-treated groups.